29 results
8-K
PTPI
Petros Pharmaceuticals Inc
28 Dec 23
Departure of Directors or Certain Officers
4:05pm
will vest upon the achievement of certain strategic goals during 2023 and 2024, provided that Mr. Boctor remains employed by the Company on the applicable
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
to pursue out strategic goals, including our Non-Prescription / OTC strategies related to Stendra®. If we do not obtain any such additional financing … , it may be difficult to effectively realize our long-term strategic goals and objectives.
Our current cash resources will not be sufficient to fund
POS AM
ycvr5k97io6
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
uvhu4zctl
30 Sep 22
Preliminary proxy
4:45pm
424B3
1c1vgl
14 Jan 22
Prospectus supplement
5:18pm
424B5
vag xvo7e
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
msbzbbeh
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
l46shg67pdtebfx
22 Nov 21
Definitive proxy
4:37pm